Miyuki Kimura

Role of human <i>MDR1</i> gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein

Yasuo Kurata, Ichiro Ieiri, Miyuki Kimura et al. · Clinical Pharmacology & Therapeutics · 2002 · 268 citations

Genetic Polymorphism of Cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese Population

Miyuki Kimura, Ichiro Ieiri, Kohsuke Mamiya et al. · Therapeutic Drug Monitoring · 1998 · 206 citations

Genetics, Genetic Epidemiology, Human Polymorphism +21

SLCO1B1 (OATP1B1, an Uptake Transporter) and ABCG2 (BCRP, an Efflux Transporter) Variant Alleles and Pharmacokinetics of Pitavastatin in Healthy Volunteers

Ichiro Ieiri, Suttasinee Suwannakul, Kazuya Maeda et al. · Clinical Pharmacology & Therapeutics · 2007 · 163 citations

Molecular Pharmacology, Genetic Determinant, Pitavastatin Area +15

Helicobacter pylori Vacuolating Cytotoxin Induces Activation of the Proapoptotic Proteins Bax and Bak, Leading to Cytochrome c Release and Cell Death, Independent of Vacuolation

Eiki Yamasaki, Akihiro Wada, Atsushi Kumatori et al. · Journal of Biological Chemistry · 2006 · 163 citations · Full text

Pharmacogenetic Characterization of Sulfasalazine Disposition Based on NAT2 and ABCG2 (BCRP) Gene Polymorphisms in Humans

Y. Yamasaki, Ichiro Ieiri, Hiroyuki Kusuhara et al. · Clinical Pharmacology & Therapeutics · 2008 · 163 citations